ºÚÁϳԹÏÍø

Success Stories

While there have been countless success stories from ºÚÁϳԹÏÍø startups, a handful of our companies have enjoyed particularly notable exits.

Lucid Diagnostics

in 2021. The company’s  esophageal cancer prevention tests were developed jointly by medical school faculty at ºÚÁϳԹÏÍø and University Hospitals. .

Rodeo Therapeutics

Publicly traded biopharmaceutical company in 2020, with the potential for up to $666 million if developmental milestones are reached. .

PolymerPlus

In 2020, , a Cleveland-based polymeric development company founded at ºÚÁϳԹÏÍø, for $25 million.

NervGen Pharma 

Vancouver-based NervGen Pharma Corp., a company founded to develop regenerative-medicine technology licensed from ºÚÁϳԹÏÍø, in 2019. .

View More of Our Startup Portfolio 

By the Numbers 

$50 million+ 

Amount of follow-on investment ºÚÁϳԹÏÍø startups have attracted

100+

Startup companies from ºÚÁϳԹÏÍø since 2001

$600 million+

Amount raised by ºÚÁϳԹÏÍø’s portfolio of spinoffs since 2017

Get in Touch

Looking to launch your own startup at ºÚÁϳԹÏÍø? We’re here to help.